EichorEICHOR
Study identifier: NCT07637539 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Not Yet Recruiting

Elastography-based Brief Alcohol Intervention in Hospitalized Individuals

Condition: Alcoholic Liver Disease (ALD) · Alcohol Use Disorder  ·  Sponsor: Oslo University Hospital

PhaseNA
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

Harmful alcohol use is a common cause of hospital admissions and the leading cause of liver cirrhosis. Timely detection of liver disease is crucial to prevent liver disease progression and reduce alcohol-related harms. The hypothesis is that proactive assessment of liver health during hospitalization may motivate reductions in alcohol use and thereby prevent disease complications and recurrent admissions more effectively than usual care. The study will recruit 500 patients at risk of alcohol-related liver disease who are admitted for inpatient care for any reason. Recruitment will be done at 8 Norwegian hospitals over an 18-month period. Participants will be randomized to liver elastography (liver stiffness measurement) and personalized alcohol counselling, or to usual care. After discharge, participants will be followed with study visits after 3, 6 and 12 months. Assessments during follow-up include self-reported alcohol use, the alcohol biomarker PEth and health-related quality of life. The primary outcome is the number of emergency hospital admissions for any reason within 2 years, collected from the Norwegian Patient Registry. The study has very low risk for the participants, with no invasive procedures or risks associated with the intervention. The potential benefit is considerably greater, with opportunities for improved health, prognosis, and quality of life for a large patient group for whom effective interventions are largely lacking. The study has very low risk for …

This description comes directly from the study's public registry record.

Talk to the study team

Håvard Midgard, Professor  ·  +47 908 30 071  ·  havardmi@gmail.com

Caroline Rootwelt  ·  +47 928 37 796  ·  carroo@ous-hf.no

Always discuss trial participation with your own doctor first.

Locations (8)

Haraldsplass Deaconess HospitalBergen, Norway
Vestre Viken Bærum HospitalDrammen, Norway
Sykehuset Nord-Trøndelag LevangerLevanger, Norway
Sykehuset Innlandet LillehammerLillehammer, Norway
Akershus University HospitalLørenskog, Norway
Diakonhjemmet HospitalOslo, Norway
Lovisenberg Diaconal HospitalOslo, Norway
Oslo University HospitalOslo, Norway

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →